Aim. To evaluate the stability of granulocyte col ony stimulating factor (G-CSF) (lenograstim) on the 14-day storage and delivery from an elastomeric infusion system (infusion device).
Methods. Infusion devices were filled with two different concentrations of G-CSF and stored for various times at 4°C under sterile conditions. Samples of G-CSF solution were then released through the infusion device and bioassayed on the G-CSF dependent murine cell line G-NFS-60.
Results. There was no statistically significant loss of bioactivity of G-CSF throughout storage and delivery from the devices for the maximum 14-day period tested at either concentration of G-CSF.
Conclusion. The devices can be filled with G-CSF and stored at 4°C for up to 14 days under sterile conditions without loss of biological activ ity, suggesting that these devices are compatible with this biological material and suitable for its short-term storage.
Tkatch LS, Tweardy DJHuman granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: Biology, clinical utility, and receptor structure and function. Lymphokine Cytokine Res.1993;12: 477- 488.
2.
Layton JEGranulocyte colony-stimulating factor: Structure, function and physiology . Growth Factors.1992;6:179-186.
3.
Linch DCLenograstim. A new glycosylated rHu-G-CSF pharmacology and clinical profile in bone marrow transplants. Br J Haematol.1992;82:274 -275.
4.
Morstyn G., Campbell L., Leischke G., et al. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimisation of dose and duration of therapy. J Clin Oncol.1989 ;7:1554-1562.
5.
Pettengell R. , Gurney H., Radford J., et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomised controlled trial. Blood.1992;80:1430 -1436.
6.
Gabrilove JL , Jakubowski A., Sher H., et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med.1988;111:887- 892.
7.
Gabrilove JL , Jakubowski A., Fain K., et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest.1988;82:1454-1461.
8.
Crawford JH, Ozer H., Stoller R., et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer . N Engl J Med.1991;325: 164.
9.
Sewell GJ, Bradford E., Rowland CGHome based cancer therapy by continuous infusion. Pharm J . 1989;243:139 -141.
10.
Thorpe R., Wadhwa M., Bird CR, et al. Detection and measurement of cytokines. Blood Rev.1992 ;6:133-148.
11.
Mire-Sluis AR, Gaines-Das R., Thorpe R.Immunoassays for detecting cytokines: What are they really measuring?J Immunol Methods. 1995;186:157-160.
12.
Wadhwa M., Bird C., Page LA, et al. Quantitative biological assays for individual cytokines. In: Balkwill FR, eds. Cytokines—A Practical Approach, 2nd ed. Oxford: IRL Press, 1995;357-391.
13.
Weinstein Y. , Ihle JN, Lavu S., et al. Trucation of the c-myb gene by a retroviral integration in an interleukin-3-dependent myeloid leukemia cell line. Proc Natl Acad Sci USA. 1986;83:5010 -5014.
14.
Mire-Sluis AR, Page L., Thorpe R.Quantitative cell line based bioassays for human cytokines. J Immunol Methods. 1995;187:191-199.
15.
Gaines Das RE, Rice LRSCAN, an exploratory program for preliminary analysis of bioassay and immunoassay data. Comput Methods ProgramsBiomed.1985;21:25.
16.
Gaines Das RE, Tydeman MSIterative weighted regression analysis of logit responses. A computer program for analysis of bioassays and immunoassays . Comput Methods Programs Biomed.1982;15:13.
17.
Hardy EM, Williamson C., Sewell GJ . An evaluation of six infusion devices for the continuous infusion of cytotoxic drugs in ambulatory patients. J Oncol Pharm Practice.1995;1:15-22.
18.
Williamson CA, Ridler C., Sewell GJA study to determine the quality of life of patients receiving low dose ambulatory chemotherapy. Hospital Pharm Practice.1993;3:197-204.
19.
Hardy EM, Sewell GJAn evaluation of ambulatory infusion devices for use in home chemotherapy programmes, in Proc. ISOPP III. Toronto, Canada: 1993.
